R G Gish Selected Research

Ribavirin (Virazole)

1/2017

Community-based real-world treatment outcomes of sofosbuvir/ledipasvir in Asians with chronic hepatitis C virus genotype 6 in the United States.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

R G Gish Research Topics

Disease

5	Chronic Hepatitis B 12/2017 - 06/2002
4	Infections 12/2014 - 06/2002
2	Liver Diseases (Liver Disease) 01/2010 - 05/2001
1	Chronic Hepatitis C 01/2017
1	Hepatitis B 06/2002
1	Fibrosis (Cirrhosis) 07/2001
1	Alcoholism (Alcohol Abuse) 07/2001
1	Autoimmune Hepatitis 05/2001

Drug/Important Bio-Agent (IBA)

4	Antiviral Agents (Antivirals)IBA 12/2017 - 05/2001
3	Hepatitis B Surface Antigens (HBsAg)FDA Link 12/2017 - 01/2010
3	Hepatitis B e AntigensIBA 01/2010 - 06/2008
3	entecavir FDA Link 01/2010 - 06/2008
2	NucleosidesIBA 01/2010 - 11/2009
2	Lamivudine (Epivir)FDA Link 01/2010 - 11/2009
1	Ribavirin (Virazole)FDA LinkGeneric 01/2017
1	sofosbuvir drug combination ledipasvirIBA 01/2017
1	AntigensIBA 01/2010
1	Alanine Transaminase (SGPT)IBA 01/2010
1	Emtricitabine (Emtriva)FDA Link 06/2002

Therapy/Procedure

4	Therapeutics 12/2017 - 05/2001
1	Duration of Therapy 06/2008
1	Liver Transplantation 07/2001